Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Wolff

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Carcinogenesis|November 1, 1986
Susceptible and resistant subgroups in genetically identical populations: response of mouse liver neoplasia and body weight to phenobarbitalG L Wolff, R L Morrissey, J J Chen
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 1, 1980
Somatomedin activity in sera of genetically small miceS P Nissley, R A Knazek, G L Wolff
Journal of Toxicology and Environmental Health|July 1, 1982
Accelerated appearance of chemically induced mammary carcinomas in obese yellow (Avy/A) (BALB/c X VY) F1 hybrid miceG L Wolff, R L Kodell, A M Cameron, et al.
The Journal of Heredity|September 1, 1978
Phaeomelanin synthesis and obesity in mice. Interaction of the viable yellow (Avy) and sombre (eso) mutationsG L Wolff, D B Galbraith, O E Domon, et al.
Pharmacology, Biochemistry, and Behavior|February 1, 1996
Neonatal MSG reduces hypothalamic DA, beta-endorphin, and delays weight gain in genetically obese (A viable yellow/alpha) miceF A Caputo, S F Ali, G L Wolff, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|September 1, 1987
Statistical variation of selected clinical pathological and biochemical measurements in rodentsD W Gaylor, R L Suber, G L Wolff, et al.
Journal of Toxicology and Environmental Health|July 1, 1991
Bladder and liver tumorigenesis induced by 2-acetylaminofluorene in different F1 mouse hybrids: variation within genotypes and effects of using more than one genotype on risk assessmentG L Wolff, D W Gaylor, B N Blackwell, et al.
Journal of Toxicology and Environmental Health|August 1, 1983
Controlled genetic variation in a subchronic toxicity assay: susceptibility to induction of bladder hyperplasia in mice by 2-acetylaminofluoreneG L Wolff, D W Gaylor, C H Frith, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 26, 1998
Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a miceG L Wolff, R L Kodell, S R Moore, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|June 3, 1999
Caloric restriction abolishes enhanced metabolic efficiency induced by ectopic agouti protein in yellow miceG L Wolff, R L Kodell, J A Kaput, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Carcinogenesis|November 1, 1986
Susceptible and resistant subgroups in genetically identical populations: response of mouse liver neoplasia and body weight to phenobarbitalG L Wolff, R L Morrissey, J J Chen
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 1, 1980
Somatomedin activity in sera of genetically small miceS P Nissley, R A Knazek, G L Wolff
Journal of Toxicology and Environmental Health|July 1, 1982
Accelerated appearance of chemically induced mammary carcinomas in obese yellow (Avy/A) (BALB/c X VY) F1 hybrid miceG L Wolff, R L Kodell, A M Cameron, et al.
The Journal of Heredity|September 1, 1978
Phaeomelanin synthesis and obesity in mice. Interaction of the viable yellow (Avy) and sombre (eso) mutationsG L Wolff, D B Galbraith, O E Domon, et al.
Pharmacology, Biochemistry, and Behavior|February 1, 1996
Neonatal MSG reduces hypothalamic DA, beta-endorphin, and delays weight gain in genetically obese (A viable yellow/alpha) miceF A Caputo, S F Ali, G L Wolff, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|September 1, 1987
Statistical variation of selected clinical pathological and biochemical measurements in rodentsD W Gaylor, R L Suber, G L Wolff, et al.
Journal of Toxicology and Environmental Health|July 1, 1991
Bladder and liver tumorigenesis induced by 2-acetylaminofluorene in different F1 mouse hybrids: variation within genotypes and effects of using more than one genotype on risk assessmentG L Wolff, D W Gaylor, B N Blackwell, et al.
Journal of Toxicology and Environmental Health|August 1, 1983
Controlled genetic variation in a subchronic toxicity assay: susceptibility to induction of bladder hyperplasia in mice by 2-acetylaminofluoreneG L Wolff, D W Gaylor, C H Frith, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 26, 1998
Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a miceG L Wolff, R L Kodell, S R Moore, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|June 3, 1999
Caloric restriction abolishes enhanced metabolic efficiency induced by ectopic agouti protein in yellow miceG L Wolff, R L Kodell, J A Kaput, et al.
Pageof 5